- Research article
- Open Access
- Open Peer Review
The clinical course of acute otitis media in high-risk Australian Aboriginal children: a longitudinal study
© Gibney et al; licensee BioMed Central Ltd. 2005
- Received: 01 November 2004
- Accepted: 14 June 2005
- Published: 14 June 2005
It is unclear why some children with acute otitis media (AOM) have poor outcomes. Our aim was to describe the clinical course of AOM and the associated bacterial nasopharyngeal colonisation in a high-risk population of Australian Aboriginal children.
We examined Aboriginal children younger than eight years who had a clinical diagnosis of AOM. Pneumatic otoscopy and video-otoscopy of the tympanic membrane (TM) and tympanometry was done every weekday if possible. We followed children for either two weeks (AOM without perforation), or three weeks (AOM with perforation), or for longer periods if the infection persisted. Nasopharyngeal swabs were taken at study entry and then weekly.
We enrolled 31 children and conducted a total of 219 assessments. Most children had bulging of the TM or recent middle ear discharge at diagnosis. Persistent signs of suppurative OM (without ear pain) were present in most children 7 days (23/30, 77%), and 14 days (20/26, 77%) later. Episodes of AOM did not usually have a sudden onset or short duration. Six of the 14 children with fresh discharge in their ear canal had an intact or functionally intact TM. Perforation size generally remained very small (<2% of the TM). Healing followed by re-perforation was common. Ninety-three nasophyngeal swabs were taken. Most swabs cultured Streptococcus pneumoniae (82%), Haemophilus influenzae (71%), and Moraxella catarrhalis (95%); 63% of swabs cultured all three pathogens.
In this high-risk population, AOM was generally painless and persistent. These infections were associated with persistent bacterial colonisation of the nasopharynx and any benefits of antibiotics were modest at best. Systematic follow up with careful examination and review of treatment are required and clinical resolution cannot be assumed.
- Tympanic Membrane
- Acute Otitis Medium
- Otitis Medium With Effusion
- Chronic Suppurative Otitis Medium
- Tympanic Membrane Perforation
Today, the majority of episodes of acute otitis media (AOM) in developed countries will resolve even if they are not treated with antibiotics. This conclusion is based on the findings of randomised placebo-controlled trials, longitudinal studies of initially withholding antibiotic treatment, and meta-analyses of randomised controlled trials. [1–3]. However, the outcomes in children from populations where there is an increased risk of complications remain uncertain.
We have described the onset of early and severe otitis media in Australian Aboriginal children[4, 5]. This is associated with dense colonisation of the nasopharynx with respiratory bacteria. In previous studies in this population, AOM (defined as the presence of an effusion plus bulging of the tympanic membrane (TM) or recent perforation) was frequently asymptomatic. AOM was often present on otoscopic examination 4 weeks after onset, despite antibiotic treatment . Children with frequent episodes of bulging of their TM were those most likely to develop new perforations. However, we could not determine whether AOM in high-risk populations initially responded to treatment and then recurred, or persisted despite treatment. The aim of this study was to describe the clinical course of AOM and the associated bacterial nasopharyngeal colonization in Aboriginal children from a remote community in the period immediately after diagnosis.
The local Human Research Ethics Committee and the community-controlled Tiwi Health Board approved the study. It took place in the year 2000 in a remote Aboriginal community situated 70 km north of Darwin (population 1300). The community has an average of 30 births per year and an infant mortality rate of 30 per 1000 live births. The standard of housing is poor and overcrowding is common .
We enrolled Aboriginal children younger than eight years who lived in the community if: i) they had AOM; ii) they were resident in the community; and iii) parents provided written consent for their participation. All children in this community develop otitis media by 12 weeks of age and around 50% experience a perforated TM in the first year of life . Children in this study were similarly prone to severe infections and all had been treated for otitis media in the past. Staff at the community health centre and otitis media researchers working on other projects made the initial diagnosis. Health centre staff examined children's ears when they presented to the children's clinic either unwell or for follow-up of a medical condition. Researchers examined children's ears as part of a regular 4 weekly surveillance program. Children with otorrhoea that had persisted for longer than six weeks were not eligible unless they had a diagnosis of AOM in the other ear. We attempted to assess children every weekday they were in the study. The planned duration of follow-up was either two weeks (AOM without perforation), or three weeks (AOM with perforation). We followed children with persistent AOM until the AOM resolved, or the study period ended.
We used a questionnaire and review of the clinic notes to collect information about each child's current and past ear health. Wax and pus were removed from the ear canal under direct vision using a voroscope (WelchAllyn LumiView). A Siegel's speculum was used for pneumatic otoscopy. Images of the TM were video recorded and classified on a standardised data collection form. The position of the TM was described as retracted (R), neutral (N), mild bulging (B1), moderate bulging (B2), and marked bulging (B3). TMs that had a perforation that was associated with mild, moderate, or marked bulging (P1-P3) were considered to be functionally intact. Examples of these different positions and "pinhole perforations" are available in a training video . Tympanometry (Grason Stadler GSI-38, Madison, Wisconsin, USA) was used in ears without any discharge. Tympanograms were classified according to a modified Jerger's classification . Tympanograms with a canal volume of <0.3 cm3 were excluded.
We classified children according to the ear with the more severe acute infection. When an assessment was only successful in one ear, we used the diagnosis of that ear and assumed the disease was unilateral. Generally, the person who made the initial diagnosis started antibiotic treatment before referring the child to this study. Medical or nursing research staff prescribed additional antibiotics during the study according to population-specific, evidence-based guidelines . We calculated compliance with prescribed antibiotics on a weekly basis (the number of doses reported as taken divided by the number of doses prescribed for that week). All families were reminded about their medication at each assessment and some had help in dispensing medicine from Aboriginal research assistants.
Our classification of otitis media was based on current population-specific, evidence-based guidelines . In this study (where close follow-up was ensured), we used the following criteria: i) Aerated middle ear-normal TM mobility and Type A or C tympanogram; ii) Otitis media with effusion (OME)-middle ear effusion behind an intact TM identified by an air-fluid level or bubble seen through a translucent TM or decreased mobility of the TM or type B tympanogram (admittance <0.2 mmho); iii) AOM without perforation-clinical diagnosis by health staff or moderate to marked bulging of an intact TM plus decreased TM mobility or Type B tympanogram; iv) AOM with perforation-evidence of recent TM perforation provided by clinical history and visualisation of fresh pus in the ear canal. The TM was intact if the perforation had already healed by the time of the assessment, and 'functionally intact' if the TM was bulging and the perforation could only be identified by pneumatic otoscopy; v) Chronic suppurative otitis media (CSOM)-TM perforation with otorrhoea present for more than six weeks; vi) Dry perforation-TM perforation with no discharge seen in the ear canal or within the middle ear space.
AOM was cured when there was no bulging and no discharge present on examination. Similarly, we described an episode of AOM as improved if: i) the ear discharge had resolved but bulging of the TM persisted in AOM with perforation, or ii) the bulging of the TM was reduced to mild in AOM without perforation. Examples of mild, moderate, and marked bulging of the TM are available in our training video . The outcome at "1 week" was determined by the examination that was closest to day 7 (at least 5 days after the diagnosis). The outcome at "2 weeks" was determined by the examination that was closest to day 14 (at least 10 days after diagnosis).
Microbiology: specimen collection and processing
We took swabs of the nasopharynx (and ear discharge if present) on up to five occasions: day 0 (the day of enrolment) and days 4–7, 10–14, 17–21 and 24–28. All swabs were then smeared for gram staining and frozen in 1.0 ml skim-milk-glucose-glycerol broth (SMGGB). We processed swabs (after completion of clinical observations) using standard methods that have been previously published . We tested isolates of pneumococcus for sensitivity to oxacillin, penicillin, erythromycin, sulphamethoxazole, tetracycline, and chloramphenicol using a disc diffusion method (calibrated dichotomous susceptibility, CDS) . Colonies resistant to oxacillin or penicillin were classified as penicillin resistant. Colonies resistant to three or more classes of antibiotics were classified as multi-resistant. Penicillin minimum inhibitory concentration (MIC) was determined by E-test and categorised according to the following breakpoints: susceptible <0.064 μg; intermediate resistance 0.064 – 1.0 μg/ml; and high resistance >1.0 μg/ml.
Features of participants and examinations
Characteristics of study participants.
No. (%) of children
Number of children
Age < 2 years
Previous history of otorrhoea
Otoscopy at start of study (per child):
Bulging (intact, no discharge)
Otorrhoea (<6 weeks)
Perforation seen (<6 weeks)
Initial diagnosis of AOM
Seventeen children had an initial diagnosis of AOM without perforation and 14 children had AOM with perforation. Nearly all children (27/31, 87%) had at least moderate bulging of the TM or recent discharge when they were first seen in this study; 13 had bilateral disease (42%). Symptoms of AOM could be assessed in 24/31 (77%) of study participants. Mothers reported otorrhea in 11/24 (46%) and ear pain in 7/24 (29%). Of the 14 children with AOM with perforation, two had a TM that appeared to have healed by the time of our examination and four had a TM that was functionally intact. All perforations seen were initially tiny in size (less than 2% of the area of the TM) and just antero-inferior to the centre of the TM.
Six children were known to be receiving antibiotics effective against respiratory pathogens at the time of the initial AOM diagnosis (amoxicillin 50 mg/kg/day). All the other children had received antibiotics for otitis media in the past but the time since their last treatment was not recorded. Following diagnosis, antibiotic treatment was started in an additional 22 children. Two of the three children not treated initially developed moderate bulging of the TM and started treatment on day 6–8 (A31 and A32). One child (A19) did not receive any antibiotics. The antibiotics prescribed were twice daily amoxicillin (25), amoxicillin-clavulanate (1), trimethoprim-sulphamethoxazole (3), or daily intramuscular procaine penicillin (1). The mean dose of penicillin or amoxicillin was 52 mg/kg/day (standard deviation 15, range 25–100). Recommended treatment duration was at least 7 days for AOM without perforation and at least 14 days for AOM with perforation. Compliance with prescribed treatment was poor. Overall, we documented 462/1151 prescribed doses (40%) as taken, and estimated that 17/30 participants (57%) took less than half their recommended treatment.
Clinical outcomes at 7 days after diagnosis of acute otitis media (AOM). AOM was considered cured when there was no bulging and no discharge present on examination. An episode of AOM was considered improved if: i) the ear discharge had resolved but bulging of the TM persisted in AOM with perforation; or ii) the bulging of the TM was reduced to mild in AOM without perforation. Despite improvement, these children still had persistent signs of suppurative infection.
Not Improved (%)
AOM without Perforation (n = 16)
AOM with Perforation (n = 14)
TOTAL (n = 30)
Clinical outcomes at 14 days after diagnosis of acute otitis media (AOM). See Table 2 for explanation of diagnostic categories.
Not Improved (%)
AOM without Perforation (n = 14)
AOM with Perforation (n = 12)
TOTAL (n = 26)
Seventeen children (55%) had a TM perforation documented at some point during the study. Of the 4 children with AOM with perforation who were followed for 6 weeks, 3 had healing and recurrence of their TM perforation documented. None of these four children had the typical otoscopic features of CSOM. In all cases the perforation was too small (usually a "pinhole") to allow adequate delivery of topical antibiotics to the middle ear space.
Overall, 93 nasopharyngeal swabs (31 children) and 38 swabs of ear discharge (13 children) were taken during this study. Each child was eligible for a maximum of five swabs (mean 3). Most of the nasopharyngeal swabs were positive for S. pneumoniae (76/93, 82%), H. influenzae (66/93, 71%) or M. catarrhalis (86/93, 95%). All but two of the nasopharyngeal swabs were positive for at least 1 pathogen (98%), and 59/93 (63%) were positive for all three otitis media pathogens. Antibiotic sensitivity testing was done in 74 of the 76 nasopharyngeal swabs positive for S. pneumoniae. Of these, 59/74 (80%) were penicillin resistant and 23/74 (31%) were multi-resistant. E-tests were available for 44 of the 59 penicillin resistant isolates: 3/44 (7%) were highly penicillin resistant.
The proportion of children with bacterial pathogens isolated from their nasopharynx.
Identification of nasopharyngeal pathogens from swabs of ear discharge was less common: S. pneumoniae 11/38 (29%), H. influenzae 12/38 (32%), or M. catarrhalis 2/38 (5%). Nineteen ear discharge swabs (50%) were positive for at least one of these pathogens and 1/38 (3%) was positive for all three otitis media pathogens.
Onset and progression of AOM with perforation
There were two patterns of resolution of AOM with perforation. In four children, the suppurative process resolved and the perforation became dry (A07, A18, A22, A29). Two of these TMs subsequently healed during the study period. More commonly, the perforation appeared to be healing while the suppurative process was ongoing (A01, A02, A03, A10, A12, A14, A20, A26, and A28). Perforations were observed to heal and re-perforate in 4 children (A02, A03, A12, and A14). In one child, the right and left TM healed and re-perforated 8 times over a 6 week period (A02), confirming that healing and re-perforation can occur frequently.
This was the first study describing the clinical course of AOM in Australian Aboriginal children. It is also the first study providing a detailed description of otoscopy findings in a population of high-risk of TM perforation. AOM (or suppurative OM) was common, usually not associated with ear pain, frequently bilateral, and often associated with perforation of the TM. In this population, AOM was generally persistent. Infections with a sudden onset and short duration were uncommon.
Strengths and limitations of the study
We used a standardised clinical assessment that included tympanometry and video-otoscopy. Since definitions of AOM vary [12, 13],. the detailed description of the position and integrity of the TM over time is especially useful (see Figure 1). This information has not been reported previously.
Limitations of the study include the small number of children enrolled and the number of scheduled examinations that were missed. This is a consequence of performing research in remote Aboriginal communities. It reflects the challenges associated with research in remote locations with small populations. Participating families are culturally different, highly mobile, and have competing priorities that are not easily predicted. These factors make daily follow-up difficult. The small sample size and relative homogeneity of the study population mean that potentially important factors that predict outcome may no be identified. However, a larger study (or observation over a longer duration) is unlikely to change our conclusion that "persistent AOM" is common in this population (overall risk of persistent AOM 77% 95%CI 58, 90). Since there are currently no data available in the world on the clinical course of AOM in a population at high-risk of AOM, the information contained within Figure 1 is both unique and clinically important.
The high rates of nasopharyngeal carriage of all three respiratory pathogens are striking. The microbiological methods used in this small study cannot determine i) which pathogens extend from the nasopharynx to the middle ear space; ii) the relative importance of concurrent infection with multiple organisms; iii) the rate of acquisition of new pathogens while on treatment; or iv) the role of antibiotic resistant bacteria. While we did not find pneumococcal penicillin resistance of organisms in the nasopahrynx to be a good predictor of outcome, the small sample size mean that important effects cannot be excluded.
Comparison with outcomes in clinical trials
Should we be surprised that "persistent AOM" is so common in this population? In published prospective studies where children have not been treated with antibiotics, the rate of clinical failure in the first week ranged from 2% to 83% [14–23]. The median failure rate was 24%. The most striking influence on reported rates of clinical failure was the definition used for this outcome. Authors that defined clinical failure in terms of persistent symptoms (fever or otalgia) reported the lowest rates of clinical failure (all <25% at the end of the first week) [14, 16–19]. The median clinical failure rate for these studies was 15%. In contrast, the five studies with the highest clinical failure rates (range 38–83%, median 73%) defined clinical failure as persistence of otoscopic signs [15, 20–23]. Only one study described both the rate of persistent symptoms (13%) and persistent otoscopic signs (73%) after seven days . Overall, these studies suggest that symptoms resolve quickly in most children with AOM not receiving antibiotics while otoscopic signs do not. Consequently, we should probably not be surprised by our findings of persistent otoscopic signs in a high-risk population where compliance with recommended antibiotic treatment is poor and antibiotic resistance is common.
Unfortunately, in nearly all published clinical trials, there is insufficient information to determine whether persistent bulging of the TM was a common finding . Persistent middle ear discharge was probably unusual (as it is a readily identified complication of AOM). None of the studies described the outcomes specifically for the subgroup of children who had AOM with perforation at the time of diagnosis. Similarly, none of these studies described the associated nasopharyngeal colonisation during episodes of AOM. However, other studies in developed countries have found that dense colonisation with multiple bacterial pathogens is unusual . This may be an important risk factor for the children included in this study.
Implications of the study
For populations where perforation of the TM and CSOM are uncommon, this study provides important information about: i) appropriate definitions for different types of OM; and ii) identification of individual children most at risk of CSOM. For high-risk populations, we believe our description of "persistent AOM" is likely to be generalisable. This persistence may be related to the severity of clinical presentation, the bacterial load (multiplicity of species and strains and their density of infection), the frequency of exposure to multiple pathogenic strains, or poor compliance with antibiotics. The early age of onset of suppurative ear infections and the low rates of reported symptoms make early recognition difficult. Consequently, active surveillance in all infants in this population is recommended.
We are extremely grateful to the Tiwi Health Board, Julanimawu Health Clinic, Murrupurttiyanawu Catholic School, and the Xavier Education Centre for supporting this study. We thank Kim Hare, Jemima Beissbarth, and Beverley Hayhurst for their assistance with data collection and laboratory procedures. Funding was provided by the National Health and Medical Research Council and the Cooperative Research Centre for Aboriginal and Tropical Health.
- Takata GS, Chan LS, Shekelle P, Morton SC, Mason W, Marcy SM: Evidence assessment of management of acute otitis media: I. The role of antibiotics in treatment of uncomplicated acute otitis media. Pediatrics. 2001, 108: 239-247. 10.1542/peds.108.2.239.View ArticlePubMedGoogle Scholar
- Glasziou PP, Del Mar CB, Sanders SL, Hayem M: Antibiotics for acute otitis media in children. Cochrane Database Syst Rev. 2005, CD000219-Google Scholar
- O'Neill P, Roberts T: Acute otitis media. Clin Evid. 2004, 324-337.Google Scholar
- Leach AJ, Boswell JB, Asche V, Nienhuys TG, Mathews JD: Bacterial colonization of the nasopharynx predicts very early onset and persistence of otitis media in Australian aboriginal infants. Pediatr Infect Dis J. 1994, 13: 983-989.View ArticlePubMedGoogle Scholar
- Boswell JB, Nienhuys TG: Patterns of persistent otitis media in the first year of life in aboriginal and non-aboriginal infants. Ann Otol Rhinol Laryngol. 1996, 105: 893-900.View ArticlePubMedGoogle Scholar
- Morris PS, Yonovitz A, Leach AJ, Mathews JD: Are respiratory mucosal diseases the same in developing countries? Diagnosing acute otitis media in a high risk population. Otitis Media Today. Edited by: Tos M. 1999, The Hague: Kugler Publications, 47-53.Google Scholar
- Hoy WE, Norman RJ, Hayhurst BG, Pugsley DJ: A health profile of adults in a Northern Territory aboriginal community, with an emphasis on preventable morbidities. Aust N Z J Public Health. 1997, 21: 121-126.View ArticlePubMedGoogle Scholar
- McCallum G, Wilson C, Thomsen P, Angeles G, Leach A, Morris P: The Ear Video Workbook-Trainer Version. Improving the diagnosis and treatment of otitis media in young Aboriginal children. Darwin, Australia. Cooperative Research Centre in Aboriginal and Tropical Health. 2002Google Scholar
- Tos M, Poulsen G, Hancke AB: Screening tympanometry during the first year of life. Acta Otolaryngol. 1979, 88: 388-394.View ArticlePubMedGoogle Scholar
- Morris P, Ballinger D, Leach A, Koops H, Hayhurst B, Stubbs L, Scott J, Anand A, Daby J, Paterson B, Yonovitz A: Recommendations for Clinical Care Guidelines on the Management of Otitis Media in Aboriginal and Torres Strait Islander Populations. Canberra: Office of Aboriginal andTorres Strait Islander Health. 2001Google Scholar
- Bell SM: Additions and modifications to the range of antibiotics tested by the CDS method of antibiotic sensitivity testing. Pathology. 1988, 20: 303-304.View ArticlePubMedGoogle Scholar
- Hayden GF: Acute suppurative otitis media in children. Diversity of clinical diagnostic criteria. Clin Pediatr (Phila). 1981, 20: 99-104.View ArticleGoogle Scholar
- Froom J, Culpepper L, Grob P, Bartelds A, Bowers P, Bridges-Webb C, et al: Diagnosis and antibiotic treatment of acute otitis media: report from International Primary Care Network. BMJ. 1990, 300: 582-586.View ArticlePubMedPubMed CentralGoogle Scholar
- Howie VM, Ploussard JH: Efficacy of fixed combination antibiotics versus separate components in otitis media. Effectiveness of erythromycin estrolate, triple sulfonamide, ampicillin, erythromycin estolate-triple sulfonamide, and placebo in 280 patients with acute otitis media under two and one-half years of age. Clin Pediatr (Phila). 1972, 11: 205-214.View ArticleGoogle Scholar
- Damoiseaux RA, van Balen FA, Hoes AW, Verheij TJ, de Melker RA: Primary care based randomised, double blind trial of amoxicillin versus placebo for acute otitis media in children aged under 2 years. BMJ. 2000, 320: 350-354. 10.1136/bmj.320.7231.350.View ArticlePubMedPubMed CentralGoogle Scholar
- Halsted C, Lepow ML, Balassanian N, Emmerich J, Wolinsky E: Otitis media. Clinical observations, microbiology, and evaluation of therapy. Am J Dis Child. 1968, 115: 542-551.View ArticlePubMedGoogle Scholar
- van Buchem FL, Dunk JH, van't Hof MA: Therapy of acute otitis media: myringotomy, antibiotics, or neither? A double-blind study in children. Lancet. 1981, 2: 883-887. 10.1016/S0140-6736(81)91388-X.View ArticlePubMedGoogle Scholar
- Appelman CL, Claessen JQ, Touw OF, Hordijk GJ, de MR: Co-amoxiclav in recurrent acute otitis media: placebo controlled study. BMJ. 1991, 303: 1450-1452.View ArticlePubMedPubMed CentralGoogle Scholar
- Kaleida PH, Casselbrant ML, Rockette HE, Paradise JL, Bluestone CD, Blatter MM, Reisinger KS, Wa;d ER, Supance JS: Amoxicillin or myringotomy or both for acute otitis media: results of a randomized clinical trial. Pediatrics. 1991, 87: 466-474.PubMedGoogle Scholar
- Laxdal OE, Merida J, Jones RH: Treatment of acute otitis media: a controlled study of 142 children. Can Med Assoc J. 1970, 102: 263-268.PubMedPubMed CentralGoogle Scholar
- Lorentzen P, Haugsten P: Treatment of acute suppurative otitis media. J Laryngol Otol. 1977, 91: 331-340.View ArticlePubMedGoogle Scholar
- van Buchem FL, Peeters van MF: Acute otitis media: a new treatment strategy. Br Med J (Clin Res Ed). 1985, 290: 1033-1037.View ArticleGoogle Scholar
- Engelhard D, Cohen D, Strauss N, Sacks TG, Jorczak-Sarni L, Shapiro M: Randomised study of myringotomy, amoxycillin/clavulanate, or both for acute otitis media in infants. Lancet. 1989, 2: 141-143. 10.1016/S0140-6736(89)90192-X.View ArticlePubMedGoogle Scholar
- Wald ER: Acute otitis media: more trouble with the evidence. Pediatr Infect Dis J. 2003, 22: 103-104. 10.1097/00006454-200302000-00001.PubMedGoogle Scholar
- Faden H, Waz MJ, Bernstein JM, Brodsky L, Stanievich J, Ogra PL: Nasopharyngeal flora in the first three years of life in normal and otitis-prone children. Ann Otol Rhinol Laryngol. 1991, 100: 612-615.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2431/5/16/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.